Sera Prognostics Stock (NASDAQ: SERA) stock price, news, charts, stock research, profile.
You can purchase shares of Sera Prognostics (NASDAQ:SERA) through any online brokerage.
Other companies in Sera Prognostics’s space includes: Macrogenics (NASDAQ:MGNX), Zentalis Pharma (NASDAQ:ZNTL), Adaptimmune Therapeutics (NASDAQ:ADAP), Fate Therapeutics (NASDAQ:FATE) and Genelux (NASDAQ:GNLX).
Sera Prognostics has a consensus price target of $8.92.
The stock price for Sera Prognostics (NASDAQ: SERA) is $4.205 last updated February 26, 2025 at 9:58 AM EST.
There are no upcoming dividends for Sera Prognostics.
Sera Prognostics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
There is no upcoming split for Sera Prognostics.
Sera Prognostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.